Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the six-month period from November 1, 2014, to April 30, 2015. The report, dated May 22, 2015, details the status of various share option and savings-related share schemes under the UK Listing Rules. It does not contain general business operations or financial performance data.
Key Financial Metrics
The filing text does not provide values for revenue, profit, cash flow, margins, debt, or liquidity. The document is strictly a regulatory return regarding the block listing of securities for employee share schemes.
Material Changes in Share Schemes
The filing reports the following movements in unallotted securities across various schemes:
- GlaxoSmithKline Share Option Plan - Ordinary Shares: Issued 2,659,471 securities; ending balance reduced to 3,719,070.
- GlaxoSmithKline Share Option Plan - ADS: Issued 2,789,086 securities; ending balance shows a negative figure of -2,367,496, indicating issuances exceeded the previous unallotted balance.
- GlaxoSmithKline plc Sharesave plan 2012: Issued 29,809 securities; ending balance reduced to 159,480.
- Other Schemes: No securities were issued or allotted during the period for the Glaxo Wellcome UK, Glaxo Wellcome International, Glaxo Wellcome 1999, SmithKline Beecham 1989 (Approved/Unapproved), and GlaxoSmithKline Savings Related Share Option Scheme. Balances remained unchanged from the previous return.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, risks, contingencies, or unusual items. The document serves solely as a statutory update on share scheme inventory.
Investor Verification Points
- Verify the negative balance (-2,367,496) reported for the GlaxoSmithKline Share Option Plan - ADS to understand if this reflects a specific accounting treatment or requires a scheme adjustment.
- Confirm the total number of shares issued (2,659,471 Ordinary + 2,789,086 ADS + 29,809 Sharesave) against the company's broader capitalization table.
- Note that no new securities were added to the block listing for any scheme during this period.